Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

68 filings reported holding BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36.3M shares of 54.3M outstanding shares and own 66.86% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.96M shares), Siren, L.L.C. (3.07M shares), TPG GP A, LLC (3.01M shares), FMR LLC (2.27M shares), Omega Fund Management, LLC (2.2M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.8M shares), BRAIDWELL LP (1.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.54M shares), Fairmount Funds Management LLC (1.28M shares), and JANUS HENDERSON GROUP PLC (1.19M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.